IMUGENE LIMITED — Director's Dealing 2024

Apr 22, 2024

Appendix 3Y Change of Director's Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX becomes ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	Imugene Limited
ABN	99 009 179 551

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of director	*Paul Hopper
Date of last notice	1 February 2024

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest	Direct and Indirect
Nature of indirect interest (including registered holder)	Director Related Parties (*Deborah Coleman - Spouse of Chairman)
Date of change	17, 18 and 19 of April 2024
No. of securities held prior to change	(1) Direct Shares - 4,275,736 ORDINARY FULLY PAID SHARES (1,381,422 Shares - Subject to voluntary escrow 12m after issue date) (2) Indirect Shares - 417,944,024 ORDINARY FULLY PAID SHARES (110,790,024 Shares - Subject to voluntary escrow 12m after issue date) (3) 2,900,000 - ESOP OPTIONS (4) 2,916,666 - LISTED OPTIONS @ $0.118, expiring 31 August 2026 (5) 3,901,500 - PERFORMANCE RIGHTS AWARD
Class	ORDINARY FULLY PAID SHARES - INDIRECT HELD
Number acquired	NIL
Number disposed	14,123,229 ORDINARY FULLY PAID SHARES
Value/Consideration	17 April 2024 - 2,380,952 @$0.0837 and 2,000,000 @$0.0830 18 April 2024 - 4,500,000 @$0.0808 19 April 2024 - 5,242,277 @$0.0727

• See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director's Interest Notice

	Appendix 3Y Change of Director's Interest Notice
No. of securities held after change	(1) Direct Shares - 4,275,736 ORDINARY FULLY PAID SHARES (1,381,422 Shares - Subject to voluntary escrow 12m after issue date) (2) Indirect Shares - 403,820,795 ORDINARY FULLY PAID SHARES (110,790,024 Shares - Subject to voluntary escrow 12m after issue date) (3) 2,900,000 - ESOP OPTIONS (4) 2,916,666 - LISTED OPTIONS @ $0.118, expiring 31 August 2026 (5) 3,901,500 - PERFORMANCE RIGHTS AWARD
Nature of change	On Market Sale of Shares by Spouse of Chairman to meet tax obligations.

Part 2 - Change of director's relevant interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration	N/A
Interest after change	N/A

Part 3 -[+] Closed period

Part 3 -+Closed period
Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?	NO
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 2